Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Multiple Myeloma
Drug:
Hemady (dexamethasone tablets)
(
GCR agonist
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
New
Source:
FDA
Excerpt:
HEMADY is a corticosteroid indicated in combination with other antimyeloma products for the treatment of adults with multiple myeloma.
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login